| HealthCo Healthcare and Wellness REIT (HCW) ORDINARY UNITS FULLY PAID |
Real Estate |
$344 |
Healthscope and Capital Management Update
|
18 Dec 2025 8:55AM |
$0.755 |
$0.625 |
fallen by
17.22%
|
|
| Gratifii Limited (GTI) ORDINARY FULLY PAID |
Information Technology |
$26 |
Trading Halt
|
18 Dec 2025 8:54AM |
$0.061 |
$0.060 |
fallen by
1.64%
|
|
GTI - Price-sensitive ASX Announcement
Full Release
Key Points
- Gratifii Limited requests trading halt
- Halt pending an announcement on material capital raise
- Halt effective from 18 December 2025
- Normal trading to resume either on 22 December 2025 or after announcement
- Company unaware of any reasons against trading halt
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bio-Gene Technology Ltd (BGT) ORDINARY FULLY PAID |
Materials |
$10 |
U.S. Department of Defense Grant Programs Advance
|
18 Dec 2025 8:53AM |
$0.023 |
$0.032 |
risen by
39.13%
|
|
BGT - Price-sensitive ASX Announcement
Full Release
Key Points
- Bio-Gene Technology is advancing two U.S. Department of Defense-funded projects.
- The Flavocide® wearable device project is in the development phase with promising entomology trials.
- The Qcide® indoor spray project awaits final agreement with U.S. partners.
- The projects are funded by a A$3.0 million grant under the Deployed Warfighter Protection program.
- These initiatives address rising insect-borne disease threats and demonstrate Bio-Gene's technological innovation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Elders Limited (ELD) ORDINARY FULLY PAID |
Consumer Staple |
$1,525 |
Elders Limited AGM Presentations and Proxy and Direct Voting
|
18 Dec 2025 8:53AM |
$6.950 |
$7.110 |
risen by
2.30%
|
|
| American Uranium Limited (AMU) ORDINARY FULLY PAID |
Materials |
$12 |
Resource Drilling Extends Lo Herma Uranium Trends by 3km
|
18 Dec 2025 8:52AM |
$0.140 |
$0.115 |
fallen by
17.86%
|
|
AMU - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of 50 drill holes covering ~16,300m for 2025.
- 3km extension of uranium mineralized trends confirmed.
- Best drill hole recorded a GT of 1.41 over 7.6m.
- Updates to MRE and Scoping Study anticipated in 2026.
- Twelve new mineral claims covering 96 hectares staked.
- Hydrogeological and drilling programs to de-risk the project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clime Capital Limited (CAM) ORDINARY FULLY PAID |
Financials |
$101 |
Update - Notification of buy-back - CAM
|
18 Dec 2025 8:52AM |
$0.690 |
$0.710 |
risen by
2.90%
|
|
| QBE Insurance Group Limited (QBE) ORDINARY FULLY PAID |
Financials |
$32,093 |
Notification of cessation of securities - QBE
|
18 Dec 2025 8:52AM |
$19.590 |
$21.370 |
risen by
9.09%
|
|
| International Graphite Limited (IG6) ORDINARY FULLY PAID |
Industrials |
$12 |
Development Approval Received for Collie Facility
|
18 Dec 2025 8:52AM |
$0.061 |
$0.060 |
fallen by
1.64%
|
|
| Lake Resources NL (LKE) ORDINARY FULLY PAID |
Materials |
$168 |
Key EIA Milestone for the Kachi Lithium Project Completed
|
18 Dec 2025 8:51AM |
$0.097 |
$0.073 |
fallen by
25.26%
|
|
LKE - Price-sensitive ASX Announcement
Full Release
Key Points
- Lake Resources completed the Management Plan for the Ramsar North Subsite.
- Kachi Lithium Project is part of the Ramsar North Subsite 'Lagunas Altoandinas y Puneñas'.
- Approval is crucial for final EIA approvals expected in 2026.
- Kachi project uses Gen 5 ion-exchange technology to eliminate evaporation ponds.
- Freshwater use is reduced by over 90% in the project.
- The project aligns with Argentina's RIGI regime and US-Argentina trade framework.
- Ramsar endorsement highlights sustainable lithium development efforts.
- Lake Resources is focused on securing strategic partnerships for project funding.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Brambles Limited (BXB) ORDINARY FULLY PAID |
Industrials |
$30,342 |
Notification of cessation of securities - BXB
|
18 Dec 2025 8:50AM |
$22.860 |
$22.450 |
fallen by
1.79%
|
|
| Gemlife Communities Group (GLF) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$1,673 |
GLF contracts new greenfield development site in Townsville
|
18 Dec 2025 8:50AM |
$5.280 |
$4.400 |
fallen by
16.67%
|
|
| Perpetual Limited (PPT) ORDINARY FULLY PAID |
Financials |
$1,827 |
Update regarding Wealth Management sale
|
18 Dec 2025 8:49AM |
$18.800 |
$15.810 |
fallen by
15.90%
|
|
PPT - Price-sensitive ASX Announcement
Full Release
Key Points
- Perpetual Limited updates on Wealth Management sale process.
- Exclusivity agreement with Bain Capital extended to Q1 2026.
- No assurance of a binding agreement or transaction.
- Perpetual committed to continuous disclosure.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PhosCo Ltd (PHO) ORDINARY FULLY PAID |
Materials |
$66 |
Completion of drilling at SAB Prospect within Gasaat
|
18 Dec 2025 8:48AM |
$0.155 |
$0.125 |
fallen by
19.35%
|
|
PHO - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of six-hole, 431m resource drilling program at SAB Prospect.
- Five holes show phosphate intersections, with assays pending.
- Preliminary measurements match previous phosphate grades.
- Assays will be integrated into the maiden MRE for SAB.
- SAB and KM prospects expected to boost project economics.
- Updated Scoping Study anticipated in 1H2026.
- Global phosphate demand is increasing, benefiting the project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Actinogen Medical Limited (ACW) ORDINARY FULLY PAID |
Health Care |
$125 |
ACW XanaMIA trial fully enrolled with 246th participant
|
18 Dec 2025 8:46AM |
$0.055 |
$0.035 |
fallen by
36.36%
|
|
ACW - Price-sensitive ASX Announcement
Full Release
Key Points
- Actinogen Medical Limited has fully enrolled 246 participants in the XanaMIA trial, exceeding the original target of 220.
- The trial is a double-blind, placebo-controlled study for mild to moderate Alzheimer's disease, with participants receiving Xanamem or placebo.
- Topline results from the 36-week treatment are expected in November 2026.
- An interim analysis of safety and efficacy futility is planned for late January 2026.
- The trial includes an open-label extension phase starting in Q1 2026, allowing all participants to receive active Xanamem.
- Xanamem is designed to control elevated cortisol levels in the brain, potentially slowing Alzheimer's disease progression.
- The trial is conducted in Australia and the US, with past and present participants eligible for the open-label phase.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Atomo Diagnostics Limited (AT1) ORDINARY FULLY PAID |
Health Care |
$27 |
Change of Director's Interest Notice x3
|
18 Dec 2025 8:45AM |
$0.034 |
$0.033 |
fallen by
2.94%
|
|
| The Calmer Co International Limited (CCO) ORDINARY FULLY PAID |
Consumer Staple |
$9 |
The Calmer Co. closes 2nd tranche of $700k Convertible Note
|
18 Dec 2025 8:44AM |
$0.003 |
$0.003 |
fallen by
16.67%
|
|
CCO - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of second tranche of $700,000 Convertible Note Raise.
- Total funding of $1.4 million across both tranches.
- Funds to support inventory buildup and working capital.
- Convertible notes available to professional and sophisticated investors.
- Interest rate of 10% per annum, increasing to 18% after July 31, 2026, if not converted.
- Conversion dependent on share price threshold by maturity dates.
- Notes secured by a General Security Deed over company assets.
- Notes not quoted on the ASX.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| RAS Technology Holdings Limited (RTH) ORDINARY FULLY PAID |
Industrials |
$34 |
Stake contract update
|
18 Dec 2025 8:44AM |
$0.965 |
$0.720 |
fallen by
25.39%
|
|
RTH - Price-sensitive ASX Announcement
Full Release
Key Points
- Contract with Stake will not be renewed in May 2026.
- Focus on growth in regulated markets including Asia, UK, and Europe.
- Non-renewal not expected to impact financials significantly in FY26.
- Strong pipeline for FY27 with a new deal with LeoVegas Group.
- Company strategy aligns with focusing on high-growth opportunities.
- Announcement authorized by the Board of RAS.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Worley Limited (WOR) ORDINARY FULLY PAID |
Industrials |
$5,689 |
Update - Notification of buy-back - WOR
|
18 Dec 2025 8:44AM |
$12.610 |
$11.240 |
fallen by
10.86%
|
|
| Aristocrat Leisure Limited (ALL) ORDINARY FULLY PAID |
Consumer Discretionary |
$27,354 |
Update - Notification of buy-back - ALL
|
18 Dec 2025 8:42AM |
$56.830 |
$45.090 |
fallen by
20.66%
|
|
| QBE Insurance Group Limited (QBE) ORDINARY FULLY PAID |
Financials |
$32,093 |
Update - Notification of buy-back - QBE
|
18 Dec 2025 8:41AM |
$19.590 |
$21.370 |
risen by
9.09%
|
|
| Qmines Limited (QML) ORDINARY FULLY PAID |
Materials |
$29 |
Mount Mackenzie Results Confirm High-Grade Gold & Silver
|
18 Dec 2025 8:41AM |
$0.047 |
$0.045 |
fallen by
4.26%
|
|
QML - Price-sensitive ASX Announcement
Full Release
Key Points
- QMines Limited focuses on copper and gold exploration in Queensland, Australia.
- They own 100% of the Mt Chalmers, Develin Creek, and Mt Mackenzie deposits.
- Mt Chalmers historically produced significant copper, gold, and silver.
- The company aims to commercialise existing deposits and explore new discoveries.
- Develin Creek shows potential for growth with upgraded mineral resources.
- Mt Mackenzie results indicate high-grade gold and silver presence.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PlaySide Studios Limited (PLY) ORDINARY FULLY PAID |
Communication Services |
$106 |
Letter to Shareholders (Dec 2025)
|
18 Dec 2025 8:39AM |
$0.218 |
$0.235 |
risen by
8.05%
|
|
PLY - Price-sensitive ASX Announcement
Full Release
Key Points
- PlaySide has restructured to be more efficient and is expecting significant cost savings.
- The company anticipates first half EBITDA between $8-10 million, partly due to a tax offset claim.
- 'MOUSE: P.I. For Hire' is highly anticipated, with a launch scheduled for March 2026.
- PlaySide is expanding its business development efforts in the MENAT region.
- The company is strengthening its leadership team to support growth in Original IP and External Projects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Carnaby Resources Limited (CNB) ORDINARY FULLY PAID |
Materials |
$108 |
Trek 1 New Footwall Lode Extension 6m @ 12.6% CuEq
|
18 Dec 2025 8:37AM |
$0.410 |
$0.390 |
fallen by
4.88%
|
|
CNB - Price-sensitive ASX Announcement
Full Release
Key Points
- Carnaby Resources Limited announced new exploration drill results at Trek 1 Prospect.
- Significant intersection of 6m at 12.6% CuEq from 211m in CBRC052.
- Extension of the Main Lode confirmed with 25.5m at 2.0% CuEq.
- High-grade copper and gold footwall lode discovered.
- Further assays pending and drilling to continue in mid-January 2026.
- Project supported by agreements with Glencore International AG.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ANZ Group Holdings Limited (ANZ) ORDINARY FULLY PAID |
Financials |
$108,602 |
2025 Annual General Meeting - Presentation and Proxy Summary
|
18 Dec 2025 8:36AM |
$36.100 |
$36.030 |
fallen by
0.19%
|
|
| ANZ Group Holdings Limited (ANZ) ORDINARY FULLY PAID |
Financials |
$108,602 |
2025 Annual General Meeting - CEO's Address
|
18 Dec 2025 8:34AM |
$36.100 |
$36.030 |
fallen by
0.19%
|
|